(Q51010265)

27 March 2018

title

Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. (English)

1 reference

27 March 2018

0 references

3

1 reference

27 March 2018

author name string

Thomson MA

1

1 reference

27 March 2018

Wilmott RW

2

1 reference

27 March 2018

Masters B

4

1 reference

27 March 2018

Francis PJ

5

1 reference

27 March 2018

Shepherd RW

6

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 September 1996

1 reference

27 March 2018

The Journal of Pediatrics

published in

1 reference

27 March 2018

volume

129

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

page(s)

367-373

1 reference

27 March 2018

Relative underweight in cystic fibrosis and its prognostic value

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Increased resting energy expenditure in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Increased energy expenditure in cystic fibrosis is associated with specific mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Measured versus predicted resting energy expenditure in infants: a need for reappraisal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Resting energy expenditure in infants with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Increased energy expenditure in young children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

The cystic fibrosis gene and resting energy expenditure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Assessment of total energy expenditure in free-living patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Resting energy expenditure before and after treatment for Pseudomonas aeruginosa infection in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Effect of salbutamol on resting energy expenditure in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Nutritional Rehabilitation Increases Resting Energy Expenditure Without Affecting Protein Turnover in Patients with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Normal energy expenditure in the infant with presymptomatic cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

RELATIONSHIP OF ENERGY EXPENDITURE TO TOTAL EXCHANGEABLE POTASSIUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Total Body Potassium in Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Evaluation of growth and changes in body composition following neonatal diagnosis of cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Routine use of hair root or buccal swab specimens for PCR analysis: advantages over using blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Neonatal screening for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Electron microprobe analysis of human labial gland secretory granules in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Regulation of CFTR Cl- conductance in secretion by cellular energy levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Energy needs and growth in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Longitudinal study of the body composition of weight gain in exclusively breast-fed and intake-measured whey-based formula-fed infants to age 3 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(96)70068-9

1 reference

27 March 2018

1 reference

27 March 2018